Perspectives in adjuvant treatment of prostate cancer.
Wirth
Manfred P
MP
Department of Urology, University Clinics Carl Gustav Carus, Technical University of Dresden, Germany. wirth-msrcs.urz.tu-dresdan.de
Froehner
Michael
M
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal